Abiomed Beats Zacks Estimate « Zacks Investment Research »

Abiomed, Inc. (ABMD) reported third quarter of fiscal 2010 results. For the quarter, net loss per share was 11 cents, beating the Zacks Consensus Estimate of loss per share of 18 cents and the year-ago loss of 20 cents.
 
Earnings Estimate Revision Trend and Zacks Rank 
The earnings estimate revision for Abiomed has demonstrated a mixed trend in the past 30 days. During the period, one out of eleven analysts has downgraded his earnings estimate while none upgraded his … [visit site to read more]


This entry was posted on Monday, February 8th, 2010 at 9:00 amand is filed under Investments. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.